Insider · CIK 0001992008
Hao-Yuan Chuang
Files at BLTE (BELITE BIO, INC). First filing Apr 13, 2026, latest Sep 9, 2026.
Hao-Yuan Chuang files SEC Form 4 as CFO and director at BLTE (BELITE BIO, INC). Since Apr 13, 2026, Hao-Yuan Chuang has reported 0 open-market buys worth $0 and 3 open-market sells worth $14M, the latest filed on Sep 9, 2026.
A track record needs three past buys with six months of prices behind them; Hao-Yuan Chuang has 0, so none is measured yet.
The newest scored trade: sold $13M of BLTE on Sep 4, 2026, filed Sep 9, 2026, scored 55 (moderate), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 3 sells worth $14M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BLTE: BELITE BIO, INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 55Moderate | BELITE BIO, INC | $13M 67,395 shares | -72% | - | |
| 18Weak | BELITE BIO, INC | $66k 367 shares | -0% | +190% from low-6% from high | |
| 42Moderate | BELITE BIO, INC | $1.1M 6,200 shares | -6% | +231% from low-5% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 12, 2026 | BLTE Belite Bio, Inc. | 93,800 0.24% of outstanding | $17M | Aug 12, 2026 | none |
| Apr 9, 2026 | BLTE Belite Bio, Inc. | 100,000 0.25% of outstanding | $18M | Apr 9, 2026 | none |
| Oct 14, 2025 | BLTE Belite Bio, Inc. | 70,054 0.21% of outstanding | $5.6M | Oct 13, 2025 | none |
| Jan 2, 2025 | BLTE Belite Bio, Inc. | 160,000 0.55% of outstanding | $10M | Jan 2, 2025 | $2.2M |
Transactions
Every row this insider has filed, 27 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary share10b5-1 | -1,633 | $180.16 | $294k | 91,800 | 34 d ago |
| Sep 4, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary share10b5-1 | -2,000 | $181.05 | $362k | 89,800 | 34 d ago |
| Sep 4, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary share10b5-1 | -2,000 | $182.49 | $365k | 87,800 | 34 d ago |
| Sep 4, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary share10b5-1 | -3,759 | $183.27 | $689k | 84,041 | 34 d ago |
| Sep 4, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary share10b5-1 | -3,569 | $184.57 | $659k | 80,472 | 34 d ago |
| Sep 4, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary share10b5-1 | -3,872 | $185.28 | $717k | 76,600 | 34 d ago |
| Sep 4, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary share10b5-1 | -4,600 | $186.35 | $857k | 72,000 | 34 d ago |
| Sep 4, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary share10b5-1 | -3,900 | $187.16 | $730k | 68,100 | 34 d ago |
| Sep 4, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary share10b5-1 | -1,900 | $188.59 | $358k | 66,200 | 34 d ago |
| Sep 4, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary share10b5-1 | -6,200 | $189.22 | $1.2M | 60,000 | 34 d ago |
| Sep 4, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary share10b5-1 | -1,800 | $190.63 | $343k | 58,200 | 34 d ago |
| Sep 4, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary share10b5-1 | -6,200 | $191.09 | $1.2M | 52,000 | 34 d ago |
| Sep 4, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary share10b5-1 | -3,398 | $192.40 | $654k | 48,602 | 34 d ago |
| Sep 4, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary share10b5-1 | -4,602 | $193.12 | $889k | 44,000 | 34 d ago |
| Sep 8, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary share10b5-1 | -2,200 | $194.28 | $427k | 41,800 | 34 d ago |
| Sep 8, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary share10b5-1 | -4,120 | $195.60 | $806k | 37,680 | 34 d ago |
| Sep 8, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary share10b5-1 | -4,475 | $196.47 | $879k | 33,205 | 34 d ago |
| Sep 8, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary share10b5-1 | -4,605 | $197.23 | $908k | 28,600 | 34 d ago |
| Sep 8, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary share10b5-1 | -2,562 | $198.05 | $507k | 26,038 | 34 d ago |
| Aug 12, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary share10b5-1 | -144 | $180.00 | $26k | 93,656 | Aug 14, 2026 |
| Aug 12, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary share10b5-1 | -223 | $180.57 | $40k | 93,433 | Aug 14, 2026 |
| Apr 21, 2026 | BLTE BELITE BIO, INC | JOther Ordinary Share | +10,000 | $0.00 | $0 | 205,264 | Apr 23, 2026 |
| Apr 9, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary share10b5-1 | -2,000 | $180.35 | $361k | 98,000 | Apr 13, 2026 |
| Apr 9, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary share10b5-1 | -2,000 | $181.40 | $363k | 96,000 | Apr 13, 2026 |
| Apr 9, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary share10b5-1 | -1,909 | $182.58 | $349k | 94,091 | Apr 13, 2026 |
| Apr 9, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary share10b5-1 | -291 | $183.08 | $53k | 93,800 | Apr 13, 2026 |
| Mar 31, 2026 | BLTE BELITE BIO, INC | AGrant or award Stock Option (right to buy)derivative | +144,868 | $0.00 | $0 | 289,736 | Apr 2, 2026 |
Questions about Hao-Yuan Chuang
Answered from the filings on this page, as of the latest one.
Is Hao-Yuan Chuang buying or selling?
In the last 12 months Hao-Yuan Chuang reported 0 open-market buys worth $0 and 3 open-market sells worth $14M on SEC Form 4; the latest was sold $13M of BLTE on Sep 4, 2026. Grants, option exercises and tax withholding are not counted.
How did Hao-Yuan Chuang's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Hao-Yuan Chuang has 0.
Where does Hao-Yuan Chuang file Form 4?
Hao-Yuan Chuang has filed Form 4 at BLTE (BELITE BIO, INC) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.